Actos Informational Video - Bladder cancer - Dan lapinski, esq. - Wilentz, goldman & spitzer, p.a.
Tip: Highlight text to annotate itX
I'm Dan Lapinski, an attorney with the law firm of Wilentz Goldman & Spitzer. Today I
would like to discuss the diabetes drug Actos. Actos or pioglitazone is a drug prescribed
to individuals suffering from Type-2 Diabetes, a condition which develops when the body does
not produce enough insulin or does not efficiently use the insulin that it produces. The product
has been on the market since 1999. On June 15, 2011, the FDA issued a safety announcement
stating that the use of Actos for over a year may be associated with an increased risk of
bladder cancer. The FDA also reported that the risk of bladder cancer increased as the
dose and duration of Actos use increased. Studies undertaken in other countries including
Germany and France have also pointed to a significantly increased risk of bladder cancer
and both countries have halted the use of Actos. The Canadian government is also undertaking
a review. Common signs and symptoms of bladder cancer include pain while urinating, blood
in the urine, back or abdominal pain, and urinary urgency. If you or someone you know
took Actos and has been diagnosed with bladder cancer, please contact Wilentz Goldman & Spitzer
at (732) 636-8000.
#6937943.1(999999.351)
#6937943.1(999999.351)
